Skip to main content
. 2021 Dec 3;12:760737. doi: 10.3389/fimmu.2021.760737

Figure 2.

Figure 2

Network map of comparisons based on five treatments in grade 1-5 adverse events (A) and grade 1-5 immune-related adverse events (B). Each circular node represents a type of treatment. The node size is proportional to the total number of patients administering a treatment (in parentheses). Each line represents a type of head-to-head comparison. The width of lines is proportional to the total number of studies comparing the connected treatments. ICI, immune checkpoint inhibitor; n, number.